China Biologic Products Holdings, Inc. (CBPO) financial statements (2020 and earlier)

Company profile

Business Address 18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING, 100125
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18418381144130
Cash and cash equivalents18414581144130
Short-term investments 38   
Restricted cash and investments  64  
Receivables3425191711
Inventory, net of allowances, customer advances and progress billings1561261018976
Inventory1561261018976
Prepaid expense   8
Deposits current assets110   
Prepaid expense and other current assets6
Deferred tax assets43322
Other undisclosed current assets1421115(2)
Total current assets:393369280264222
Noncurrent Assets
Property, plant and equipment132105807351
Long-term investments and receivables5449181111
Long-term investments119181111
Accounts and financing receivable, after allowance for credit loss4340   
Intangible assets, net (including goodwill)   34
Intangible assets, net (excluding goodwill)   34
Deposits noncurrent assets  131415
Restricted cash and investments  40313
Other noncurrent assets253 
Deferred tax assets, net1    
Other undisclosed noncurrent assets23241286
Total noncurrent assets:21218216713989
TOTAL ASSETS:605551447404311
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14141397
Accounts payable610543
Taxes payable75845
Debt  84108
Due to related parties   74
Other undisclosed current liabilities6057233828
Total current liabilities:73721216348
Noncurrent Liabilities
Long-term debt and lease obligation  4030 
Long-term debt, excluding current maturities  4030 
Liabilities, other than long-term debt10131939
Deferred revenue and credits45333
Deferred tax liabilities, net  8(3)3
Other liabilities78833
Other undisclosed noncurrent liabilities  (8)3(3)
Total noncurrent liabilities:101351366
Total liabilities:848517210054
Stockholders' equity
Stockholders' equity attributable to parent462382212238195
Common stock00000
Treasury stock, value(56)(56)(77)(30) 
Additional paid in capital105105247262
Accumulated other comprehensive income (loss)(25)(0)202214
Retained earnings438334245174119
Stockholders' equity attributable to noncontrolling interest5985636662
Total stockholders' equity:521467275304257
TOTAL LIABILITIES AND EQUITY:605551447404311

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues341296243203185
Cost of revenue(124)(106)(80)(65)(59)
Gross profit:217190163138126
Operating expenses(73)(57)(47)(52)(55)
Other operating income, net    1
Other undisclosed operating income (loss)  (5)13
Operating income:1441331118774
Nonoperating income1031257
Investment income, nonoperating862645
Interest and debt expense(0)(2)(4)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes  411
Income from continuing operations before equity method investments, income taxes:1541331239281
Income (loss) from equity method investments3(1)923
Other undisclosed income (loss) from continuing operations before income taxes(2)3  (3)
Income from continuing operations before income taxes:1541351319581
Income tax expense(25)(21)(27)(16)(15)
Income before gain (loss) on sale of properties:1291141057966
Other undisclosed net loss  (9)(2) 
Net income:129114967766
Net loss attributable to noncontrolling interest(24)(25)(25)(22)(21)
Net income attributable to parent:10589715545
Other undisclosed net loss available to common stockholders, basic(3)(2)(1)(0)(0)
Net income available to common stockholders, basic:10287705445
Other undisclosed net loss available to common stockholders, diluted    (2)
Net income available to common stockholders, diluted:10287705443

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:129114967766
Other undisclosed comprehensive income (loss)(31)(24)(2)92
Comprehensive income:9790948668
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(19)(21)(25)2421
Other undisclosed comprehensive loss, net of tax, attributable to parent   (48)(42)
Comprehensive income, net of tax, attributable to parent:7869696247

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: